dr. Marko Anderluh
št.: 21456

farmacevtska kemija, glikomimetiki, glikokemija, zaviralci DNA giraze, zaviralci galektina-8, zaviralci glikoziltransferaz

Prof. Dr. Marko Anderluh Organizational and leadership • 2003-2006 Postgraduate European Radiopharmacy Course, Block 1: Pharmacy, Ljubljana, Slovenia • 17-21/06/2007: 5th JMMC Meeting, Portorož, Slovenia • 29/9-1/10/2011: 4th BBBB-Bled International Conference, Bled, Slovenia. • 2013-2021: president of the Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society • 14-16/05/2015 - today: Symposium at the General Assembly of the Slovenian Pharmaceutical Society, Portorož, Slovenia • 7-10/7/2015: 9th JMMC Meeting, Athens, Greece. • 2015-2021: vice-president of the Slovenian Pharmaceutical Society • 28/8-1/9/2016: EFMC-ISMC 2016 International Symposium on Medicinal Chemistry, Manchester, UK. • 25-28/6/2017: 10th JMMC Meeting, Dubrovnik, Croatia • 2-6/9/2018: EFMC-ISMC 2018 International Symposium on Medicinal Chemistry, Ljubljana, Slovenia • 27-30/6/2019: 11th JMMC Meeting, Prague, Czech Republic • 28/8-2/9/2021: EFMC-ISMC 2021 International Symposium on Medicinal Chemistry, Basel, Switzerland • 2021: the President of the Slovenian Pharmaceutical Society • 23-25/11/2022: 12th JMMC Meeting, Bratislava, Slovakia Research projects/grants • EU project: EUR-Intafar. Funded by: FP6, Contract number (LSHM-CT-2004-512138) • EU project: MAREX. Funded by: FP7, Project Reference: 245137 • Innovative synthesis of substance vildagliptin. Patent: EU/international patent: EP 2459531 B1, 2019-09-11. • Bilateral project PROTEUS BI-FR/12-13-PROTEUS-007, ARRS (2012-2013), in collaboration with Assist. Prof. Dr. Sylvie Mavel, University of Tours, France. • Bilateral project ARRS-BI-RS-JR-Prijava/2013/32, 2014-2015, in collaboration with Assoc. Prof. Dr. Andrija Šmelcerović, University of Niš, Serbia. • EU FP7 project ORCHID (2011-2015), ID: 261378, Leadership: pharmaceutical company GlaxoSmithKline • 2014-2015: bilateral project ARRS-BI-RS-JR-Prijava/2013/32, with Assoc. Prof. Dr. Andrija Šmelcerović, University of Niš, Serbia • ARIS project L1-6745 Combating bacterial resistance: optimisation of bacterial cell wall biosynthesis inhibitors (2014―2017) (Leader: Prof. Dr. Stanislav Gobec) • ARIS project J1-8152 Inhibition of Staphylococcus aureus cell wall remodeling (2017―2020) (Leader: Prof. Dr. Dušan Turk) • ARIS project J3-9256 (2018―2021) Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants (Leader: Izr. Prof. Dr. Žiga Jakopin) • 2017-2021: H2020 MSCA-ITN-EJD project PhD4GlycoDrug (https://www.phd4glycodrug.eu/, ID: 765581). Role: Prof. Dr. Marko Anderluh was the major coordinator of the project. • ARIS project J1-2483 Radiopharmaceuticals with antagonistic activity on CCK2R (2020―2023) (Leader: Prof. Dr. Marko Anderluh) • 2023-2027: Horizon EU MSCA-DN project GlyCanDrug (ID: 101119601). Role: local coordinator of the project. • 2023-2027: Horizon EU MSCA-PF project PROTAG-8 (ID: 101103550). Role: Prof. Dr. Marko Anderluh is the major coordinator of the project. • ARIS Project N1-0417 Mono- and multivalent inhibitors of galectin-8 in tumour-associated (lymph)angiogenesis, (2024-2027) (Leader: Prof. Dr. Marko Anderluh) Grants before the tenure track • 1994-2000: Zois scholarship for gifted students • 2000-2004: Young researcher postgraduate scholarship • 2006: Futurum 2006 grant, Ad Futura Awards • 2021: Zois Award for important discovery and sustainable development in the field of antibacterial agents in the Republic of Slovenia • 2021: The most excellent research achievements of the University of Ljubljana • 2020: University of Ljubljana Rector's award (second place) • 2015: Recognition for a WP leader of the EFMC • 2009: a "Svečana listina mladim visokošolskim učiteljem", by University of Ljubljana • 2006: Futurum 2006 award for outstanding PhD thesis of Ad Futura • 2005: 35th Krka Prize for top 5 research achievements in the year 2005 Bibliography https://bib.cobiss.net/bibliographies/si/webBiblio/bib201_20220217_104347_21456.html (national catalogue system)